Using AI to help detect gastric cancer early in France
Early Detection of Gastric Cancer in France: Evaluation of the Diagnostic Capacity of a Computer-aided Diagnostic System (CADx) Compared to Endoscopists. EGC-France
Hospices Civils de Lyon · NCT05928819
This study is testing a computer program to see if it can help doctors find gastric cancer earlier in patients getting a stomach exam in France.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon (other) |
| Locations | 1 site (Lyon) |
| Trial ID | NCT05928819 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates a computer-aided diagnosis system (CADx) designed to improve the early detection of gastric cancer. By comparing the detection rates of gastric neoplastic lesions identified by the CADx system against those identified by experienced endoscopists, the study aims to assess the effectiveness of this diagnostic tool. The focus is on patients undergoing gastroscopy for gastric lesion resection, with the goal of identifying lesions at an earlier stage to improve patient outcomes. The study is conducted in France, where gastric cancer remains a significant health concern.
Who should consider this trial
Good fit: Ideal candidates include patients aged 18 and older who require diagnostic or therapeutic gastroscopy for gastric lesions and have French Health Insurance coverage.
Not a fit: Patients who have previously undergone lesion resection or do not have any gastric lesions will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier detection of gastric cancer, significantly improving survival rates for patients.
How similar studies have performed: Other studies have shown promise in using AI for cancer detection, suggesting that this approach could be beneficial, though this specific application is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * both gender patients even or older than 18 years old * patient in need of proven diagnostic or therapeutic gastroscopy for gastric lesion resection * patient with French Health Insurance coverage * obtaining of oral non opposition to research after loyal, clear and complete delivery of information Exclusion Criteria: * previous attempt of lesion resection * patient with no gastric lesion * inadequate examination quality (gastroparesis) * patient with health disorders needing short procedure times
Where this trial is running
Lyon
- Hôpital Edouard Herriot — Lyon, France (RECRUITING)
Study contacts
- Study coordinator: Pierre LAFEUILLE, MD
- Email: pierre.lafeuille@chu-lyon.fr
- Phone: 33472110143
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gastric Cancer, diagnostic tool, AI, CAD, gastric cancer, therapeutic choice guidance